Upregulation of microRNA-132 in gastric cancer promotes cell proliferation via retinoblastoma 1 targeting

Molecular Medicine Reports
Feng-Yu GaoShi-Ying Xuan

Abstract

Gastric cancer is one of the most frequent malignancies and a leading cause of cancer-related mortality worldwide. MicroRNAs (miRs), a class of small non‑coding RNAs, have been shown to be critical in tumorigenesis. In the present study, the expression levels of miR‑132 were analyzed in gastric cancer samples using quantitative reverse transcription‑polymerase chain reaction. In addition, the cell viability, proliferation and invasion abilities were determined in two gastric cancer cell lines, NCI‑N87 and MGC80‑3, that were transfected with miR‑132 mimics or antisense oligos. It was found that miR‑132 expression was significantly upregulated in gastric cancer tissues when compared with adjacent non‑cancerous tissues. At the molecular level, the data demonstrated that miR‑132 inhibits the protein levels of retinoblastoma 1 (RB1) by targeting the 3'‑untranslated region. Furthermore, reintroduction of RB1 markedly attenuated the proliferative roles of miR‑132 overexpression. Therefore, the present results indicate that the miR‑132/RB1 regulatory axis may be a potential novel diagnostic and therapeutic target for the treatment of gastric cancer.

References

Oct 24, 2009·Nature Reviews. Cancer·Hui-Zi ChenGustavo Leone
May 21, 2010·Cancer Research·Aya ShinozakiMasashi Fukayama
Feb 9, 2012·Oncogene·A FormosaE Candi
Nov 21, 2012·Nature Reviews. Gastroenterology & Hepatology·Shumei Song, Jaffer A Ajani
Jun 27, 2013·Nature Reviews. Molecular Cell Biology·Stefan L Ameres, Phillip D Zamore
Jul 3, 2013·Nature Reviews. Genetics·Kailiang Sun, Eric C Lai
Aug 29, 2013·Cancer Letters·Yujie DengTianhua Zhou
Nov 1, 2013·Nature Reviews. Drug Discovery·Hui LingGeorge A Calin
Nov 2, 2013·The Lancet Oncology·Lin ShenLi-Tzong Chen
Nov 20, 2013·Digestive Diseases and Sciences·Jiaojiao MaDaiming Fan
Jan 23, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jin WangYifan Kang
Mar 14, 2014·Diagnostic Pathology·Xiaowen LiuYanong Wang
Jun 11, 2014·World Journal of Gastroenterology : WJG·Yong-Bin ZhengShi-Lun Tong
Aug 19, 2014·World Journal of Gastroenterology : WJG·Vivian Yvonne Shin, Kent-Man Chu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.